Default: CNS and Neurological Disorders - Drug Targets

ISSN: 1871-5273

Journal Home

Journal Guideline

CNS and Neurological Disorders - Drug Targets Q2 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

CNS and Neurological Disorders - Drug Targets is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 96. It has a price of 2395 €. It has an SJR impact factor of 0,62 and it has a best quartile of Q2. It has an SJR impact factor of 0,62.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

2395 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

CNS and Neurological Disorders - Drug Targets

0,62

SJR Impact factor

96

H Index

120

Total Docs (Last Year)

223

Total Docs (3 years)

12672

Total Refs

632

Total Cites (3 years)

207

Citable Docs (3 years)

2.79

Cites/Doc (2 years)

105.6

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Commentary-1 (Research Highlights: USP30 Regulates the Mitophagy-Mediated Neuroprotection in Parkinson's Disease)

View more

Commentary-2: Repairing the Dopamine System in the Brain with Adult Neurogenesis

View more

Vertical and Horizontal Convergences of Targeting Pathways in Combination Therapy with Baicalin and Jasminoidin for Cerebral Ischemia

View more

TDP-43 as a Modulator of Synaptic Plasticity in a Mouse Model of Spinal Motoneuron Degeneration

View more

Major Depressive Disorder and Type II Diabetes Mellitus: Mechanisms Underlying Risk for Alzheimer's Disease

View more

Inquiries into the Biological Significance of Transmembrane AMPA Receptor Regulatory Protein (TARP) gamma-8 Through Investigations of TARP gamma-8 Null Mice§

View more

Microglial Senescence

View more

Meet Our Editorial Board Member

View more

Metformin: Repurposing Opportunities for Cognitive and Mood Dysfunction

View more

Beneficial and Adverse Effects of Molecularly Targeted Therapies for Acute Promyelocytic Leukemia in Central Nervous System

View more

Preconditioning by Oxygen-Glucose Deprivation Preserves Cell Proliferation and Reduces Cytotoxicity in Primary Astrocyte Cultures

View more

Evoked Potential in Panic Disorder Patients: A Systematic Review

View more
SHOW MORE ARTICLES

Elevated C-reactive Protein Levels in Women with Bipolar Disorder may be Explained by a History of Childhood Trauma, Especially Sexual Abuse, Body Mass Index and Age

View more

Psychological Treatments for Cognitive Dysfunction in Major Depressive Disorder: Current Evidence and Perspectives§

View more

Characterization of Cancer Stem Cells and Primary Cilia in Medulloblastoma

View more

Neuropharmacological Aspects of Crocus sativus L.: A Review of Preclinical Studies and Ongoing Clinical Research

View more

Genetic Polymorphisms Might Predict Suicide Attempts in Mental Disorder Patients: A Systematic Review And Meta-Analysis

View more

Testosterone Replacement Therapy in Older Male Subjective Memory Complainers: Double-Blind Randomized Crossover Placebo-Controlled Clinical Trial of Physiological Assessment and Safety

View more

Biochemical Markers for Brain Injury Monitoring in Children with or without Congenital Heart Diseases

View more

Meet Our Editorial Board Member

View more

Message from the Editor-in-Chief:

View more

Meet Our Editorial Board Member

View more

Therapeutic Targeting of Chemokines and Chemokine Receptors in Multiple Sclerosis: Opportunities and Challenges

View more

Cognitive Dysfunction in Depression -Pathophysiology and Novel Targets

View more

FAQS